PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Symptom | C0948265|metabolic syndrome |
| Sentences | 42 |
| PubMedID- 26089893 | Using the liver insulin receptor knockout (lirko) mouse as a model of pure hepatic insulin resistance it has been demonstrated that hepatic insulin resistance alone can produce both the dyslipidemia and increasing risk of atherosclerosis associated with the metabolic syndrome . |
| PubMedID- 22493605 | Background: the renin-angiotensin-aldosterone system plays an important role in the development and progression of hypertension and accelerated atherosclerosis (atheroscleropathy) associated with the cardiorenal metabolic syndrome and type 2 diabetes mellitus. |
| PubMedID- 21738343 | Differential relationship between metabolic syndrome score and severity of coronary atherosclerosis as assessed by angiography in a non-diabetic and diabetic korean population. |
| PubMedID- 21827549 | Background: carotid intima-media thickness (cimt) is a potential indicator of subclinical atherosclerosis in patients with metabolic syndrome (mets). |
| PubMedID- 25247758 | metabolic syndrome is correlated with carotid atherosclerosis in patients with lupus nephritis. |
| PubMedID- 21816063 | Furthermore, our findings suggest that the observed association between uric acid and carotid atherosclerosis may be attributed to metabolic syndrome-dependent and -independent mechanisms. |
| PubMedID- 20398632 | Background: oxidative stress induced by free fatty acids plays a critical role in the pathogenesis of endothelial dysfunction and atherosclerosis in patients with metabolic syndrome. |
| PubMedID- 23704519 | Human epicardial fat in type 2 diabetic and metabolic syndrome patients with coronary atherosclerosis (cad) expressed amounts of ucp1 similar to those expressed in control subjects without diabetes, metabolic syndrome, and cad (20). |
| PubMedID- 25218813 | Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification. |
| PubMedID- 25633268 | Aims: matrix metalloproteinases (mmps) and their tissue inhibitors (timps) are dysregulated in metabolic syndrome (mets) and associated with atherosclerosis and cardiovascular disease (cvd). |
| PubMedID- 25589838 | metabolic syndrome criteria as predictors of subclinical atherosclerosis based on the coronary calcium score. |
| PubMedID- 23776788 | il-18 has been shown to be highly expressed in atherosclerotic plaques, mainly in plaque macrophages, and in particular in unstable plaques, and the circulating il-18 level is a useful biomarker for atherosclerosis prone patients with metabolic syndrome. |
| PubMedID- 20689417 | Recent findings: individuals infected with hiv frequently demonstrate a metabolic syndrome associated with atherosclerosis and cardiovascular disease. |
| PubMedID- 20727144 | Subclinical carotid atherosclerosis is associated with metabolic syndrome . |
| PubMedID- 22291799 | In our study, the level of inflammatory markers crp and tnf-α, agents of the coagulation system activation and fibrinolysis (d-dimers, fibrinogen) participating in the inflammatory process of atherosclerosis were higher in patients with the metabolic syndrome as compared with healthy women. |
| PubMedID- 22738646 | The metabolic syndrome and progression of carotid atherosclerosis over 13 years. |
| PubMedID- 24072083 | Carotid intima-media thickness (imt) is a potential indicator of subclinical atherosclerosis in patients with metabolic syndrome (ms). |
| PubMedID- 19762024 | The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. |
| PubMedID- 24843601 | Adipocytokines play an important role in the pathogenesis of atherosclerosis through inflammation associated with obesity and metabolic syndrome. |
| PubMedID- 25546822 | Interestingly, therefore, myd88-dependent cooperation between myeloid and endothelial cells was recently proven to be key to the promotion of the vascular inflammation and atherosclerosis associated with metabolic syndrome 64. thus, because myd88 is likely to be a key player in integrating cross-talk among tlr, fcr, and complement receptors, in concert with the reduction in igg and c3a deposition, our finding that es-62 and anti–il-22 down-regulate myd88 expression in kidney cells provides an effective mechanism for protecting against kidney inflammation. |
| PubMedID- 24490696 | Tempol attenuates atherosclerosis associated with metabolic syndrome via decreased vascular inflammation and nadph-2 oxidase expression. |
| PubMedID- 22383927 | El plasma concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis 3. |
| PubMedID- 21772967 | Another wasid substudy has demonstrated that metabolic syndrome is associated with intracranial atherosclerosis and confers a higher risk of major vascular events in these patients. |
| PubMedID- 21497934 | Aim: the goal of this study was to investigate the association between omentin-1 and carotid atherosclerosis in patients with metabolic syndrome (mets). |
| PubMedID- 22919126 | This suggests that vascular atherosclerosis resulting from metabolic syndrome may be part of the pathophysiology of ed in men with hypogonadism. |
| PubMedID- 23798936 | A recent population-based study reported that the association of a metabolic syndrome with subclinical atherosclerosis was independent of its association with the biomarkers of endothelial damage and oxidative stress. |
| PubMedID- 23398954 | We aimed to study the association of chemokine cxcl16/cxcr6 and carotid atherosclerosis in patients with metabolic syndrome. |
| PubMedID- 24481091 | Relation between mean platelet volume and subclinical atherosclerosis in patients with metabolic syndrome. |
| PubMedID- 23245314 | Decreased serum obestatin consequent upon trib3 q84r polymorphism exacerbates carotid atherosclerosis in subjects with metabolic syndrome. |
| PubMedID- 21251304 | Circulating interleukin-18: a specific biomarker for atherosclerosis-prone patients with metabolic syndrome. |
| PubMedID- 20470376 | Association between serum levels of incretins, glucagon-like peptide-1 (glp-1) and gastric inhibitory polypeptide (gip), and metabolic syndrome components in patients with atherosclerosis-prone conditions. |
| PubMedID- 25233795 | Association of metabolic syndrome with coronary atherosclerosis in non-diabetic postmenopausal women. |
| PubMedID- 23409033 | Implication of progranulin and c1q/tnf-related protein-3 (ctrp3) on inflammation and atherosclerosis in subjects with or without metabolic syndrome. |
| PubMedID- 25242580 | Therefore, the intervention with anti-inflammatory agents may effectively delay the formation and progression of atherosclerosis in patients with metabolic syndrome. |
| PubMedID- 20039893 | The metabolic syndrome is associated with subclinical atherosclerosis independent of insulin resistance: the guangzhou biobank cohort study-cvd. |
| PubMedID- 23773268 | Dysregulation of adipocytokines caused by visceral fat accumulation is regarded as one of the major pathophysiological mechanisms of atherosclerosis associated with the metabolic syndrome. |
| PubMedID- 26381729 | Recent studies suggested that uoc could serve as a novel biomarker for carotid atherosclerosis in patients with hypertension or metabolic syndrome . |
| PubMedID- 21190590 | In our previous study of a specific atherosclerosis-prone population with obesity and metabolic syndrome (mets), we did not find any significant role for at-ldl . |
| PubMedID- 22813569 | Association of metabolic syndrome with carotid atherosclerosis in the young north indian population. |
| PubMedID- 24470352 | Also observed defects in akt2 signaling which may contribute to accelerated atherosclerosis in patients with metabolic syndrome (18). |
| PubMedID- 25206497 | It is also a specific biomarker for atherosclerosis-prone patients with metabolic syndrome. |
| PubMedID- 21321616 | Detection of the parameters for early atherosclerosis in patients with metabolic syndrome and periodontitis. |
Page: 1